BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20837803)

  • 1. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis.
    Young RC; Hodge DO; Liesegang TJ; Baratz KH
    Arch Ophthalmol; 2010 Sep; 128(9):1178-83. PubMed ID: 20837803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.
    N Engl J Med; 1998 Jul; 339(5):300-6. PubMed ID: 9696640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts.
    Bhatt UK; Abdul Karim MN; Prydal JI; Maharajan SV; Fares U
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD007824. PubMed ID: 27902849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
    Carter SB; Cohen EJ
    Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection.
    Uchoa UB; Rezende RA; Carrasco MA; Rapuano CJ; Laibson PR; Cohen EJ
    Arch Ophthalmol; 2003 Dec; 121(12):1702-4. PubMed ID: 14662588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group.
    Cornea; 2001 Mar; 20(2):123-8. PubMed ID: 11248812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Adherence (Compliance) to Oral Acyclovir Prophylaxis in the Recurrence of Herpetic Keratitis: Long-Term Results From a Pediatric Cohort.
    Luccarelli SV; Lucentini S; Martellucci CA; Marelli L; Sacchi M; Nucci P
    Cornea; 2021 Sep; 40(9):1126-1131. PubMed ID: 33201055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features of Herpes Simplex Keratitis in a Korean Tertiary Referral Center: Efficacy of Oral Antiviral and Ascorbic Acid on Recurrence.
    Kim GN; Yoo WS; Park MH; Chung JK; Han YS; Chung IY; Seo SW; Yoo JM; Kim SJ
    Korean J Ophthalmol; 2018 Oct; 32(5):353-360. PubMed ID: 30311457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
    Liu S; Pavan-Langston D; Colby KA
    Ophthalmology; 2012 Oct; 119(10):2003-8. PubMed ID: 22796308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.
    Garcia DD; Farjo Q; Musch DC; Sugar A
    Cornea; 2007 Sep; 26(8):930-4. PubMed ID: 17721290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral acyclovir for the management of herpes simplex virus keratitis in children.
    Schwartz GS; Holland EJ
    Ophthalmology; 2000 Feb; 107(2):278-82. PubMed ID: 10690825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis.
    Lairson DR; Begley CE; Reynolds TF; Wilhelmus KR
    Arch Ophthalmol; 2003 Jan; 121(1):108-12. PubMed ID: 12523894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. The Epithelial Keratitis Trial. The Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 1997 Jun; 115(6):703-12. PubMed ID: 9194719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral antiviral prophylaxis in preventing ocular herpes simplex virus recurrences in patients with and without self-reported atopy.
    Rezende RA; Bisol T; Hammersmith K; Rapuano CJ; Lima AL; Webster GF; Freitas JF; Laibson PR; Cohen EJ
    Am J Ophthalmol; 2006 Oct; 142(4):563-7. PubMed ID: 17011845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Management of Herpes Simplex Keratitis With Oral Valganciclovir in Patients Unresponsive or Allergic to Conventional Antiviral Therapy.
    Koseoglu ND; Strauss BR; Hamrah P
    Cornea; 2019 Jun; 38(6):663-667. PubMed ID: 30882539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of herpes simplex virus keratitis in France.
    Labetoulle M; Auquier P; Conrad H; Crochard A; Daniloski M; Bouée S; El Hasnaoui A; Colin J
    Ophthalmology; 2005 May; 112(5):888-95. PubMed ID: 15878072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis.
    Akova YA; Onat M; Duman S
    Ocul Immunol Inflamm; 1999 Mar; 7(1):51-60. PubMed ID: 10410875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.
    Moyes AL; Sugar A; Musch DC; Barnes RD
    Arch Ophthalmol; 1994 May; 112(5):601-7. PubMed ID: 8185515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.